掌蹠膿疱症の世界市場レポート 2025年

掌蹠膿疱症市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.9％で28億4,000万米ドルに成長します。予測期間の成長は、生物学的療法の採用増加、皮膚科学研究への投資増加、新規治療パイプラインの増加、個別化医療への需要の高まり、慢性皮膚疾患の有病率の増加が牽引するとみられます。予測期間の主な動向としては、皮膚科学研究の発展、生物学的製剤や免疫調整剤へのシフト、皮膚科診断における人工知能の統合、高度な局所製剤の開発、皮膚科学研究における機械学習の利用などが挙げられます。

皮膚疾患の有病率の上昇は、掌蹠膿疱症市場の成長を促進すると予想されます。皮膚疾患は、皮膚の構造、機能、外観に影響を与える疾患であり、その発生率の増加は、環境の変化、生活習慣、遺伝的要因に起因しています。大気汚染、異常気象、有害な化学物質への暴露などの環境の影響は、皮膚を刺激し、湿疹やにきびなどの症状を引き起こす可能性があります。掌蹠膿疱症は、主に手のひらや足の裏を侵し、膿疱、発赤、鱗屑を引き起こす慢性皮膚疾患です。この症状は、皮膚の健康を改善し、不快感を軽減するための様々な治療で管理することができます。例えば、2022年に国際湿疹協議会は、全世界で約2億2,300万人がアトピー性皮膚炎に罹患しており、そのうち4,300万人が1～4歳であると報告しています。皮膚疾患の流行に伴い、掌蹠膿疱症市場の成長は加速しています。

掌蹠膿疱症市場の各社は、炎症経路を標的とするモノクローナル抗体などの革新的な治療法を開発し、患者の予後を改善しています。モノクローナル抗体（mAbs）は、単一のB細胞クローンによって産生される同一の抗体であり、治療または診断目的で特定の抗原を標的とするように設計されています。例えば、2023年8月、日本の製薬会社である協和キリン株式会社は、ルミセフの掌蹠膿疱症治療に対する一部承認を日本で取得しました。ルミセフはIL-17を阻害する標的治療薬であり、乾癬や掌蹠膿疱症などの炎症性疾患に対して迅速かつ持続的な緩和をもたらします。ルミセフの目標は、慢性皮膚疾患患者の炎症を抑え、生活の質を高めることです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の掌蹠膿疱症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の掌蹠膿疱症市場：成長率分析
• 世界の掌蹠膿疱症市場の実績：規模と成長, 2019-2024
• 世界の掌蹠膿疱症市場の予測：規模と成長, 2024-2029, 2034F
• 世界の掌蹠膿疱症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の掌蹠膿疱症市場：治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所治療
• 全身治療
• 生物学的製剤
• 光線療法
• 世界の掌蹠膿疱症市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 皮膚科クリニック
• 在宅ケア設定
• 世界の掌蹠膿疱症市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン薬局
• 小売薬局
• 病院
• 世界の掌蹠膿疱症市場：タイプ別サブセグメンテーション、局所治療、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• ビタミンD類似体
• カルシニューリン阻害剤
• 角質溶解剤
• 世界の掌蹠膿疱症市場：タイプ別サブセグメンテーション、全身治療、実績と予測, 2019-2024, 2024-2029F, 2034F
• レチノイド
• 免疫抑制剤
• ホスホジエステラーゼ4（PDE4）阻害剤
• コルチコステロイド
• 世界の掌蹠膿疱症市場：タイプ別サブセグメンテーション、生物製剤、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍壊死因子（TNF）阻害剤
• インターロイキン-17（IL-17）阻害剤
• インターロイキン-23（IL-23）阻害剤
• インターロイキン-12/23（IL-12/23）阻害剤
• 世界の掌蹠膿疱症市場：タイプ別サブセグメンテーション、光線療法、実績と予測, 2019-2024, 2024-2029F, 2034F
• ナローバンドUVB療法（NB-UVB）
• ソラレン＋紫外線A波（PUVA）療法
• エキシマレーザー療法
• 標的光線療法

第7章 地域別・国別分析

• 世界の掌蹠膿疱症市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の掌蹠膿疱症市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 掌蹠膿疱症市場：競合情勢
• 掌蹠膿疱症市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline PLC（GSK）
• Amgen Inc.
• C.H. Boehringer Sohn AG & Co. KG
• Bausch Health Companies Inc.
• Chugai Pharmaceutical Co. Ltd.
• Janssen Pharmaceuticals Inc.
• Kyowa Kirin Co. Ltd.
• Swedish Orphan Biovitrum AB（Sobi）
• Almirall S.A.
• MorphoSys AG
• MoonLake Immunotherapeutics AG
• Aristea Therapeutics Inc.
• AnaptysBio Inc.
• Taiho Pharmaceutical Co. Ltd.
• Kamari Pharma Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 掌蹠膿疱症市場2029：新たな機会を提供する国
• 掌蹠膿疱症市場2029：新たな機会を提供するセグメント
• 掌蹠膿疱症市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Palmoplantar pustulosis is a chronic skin disorder characterized by the development of pustules (small, pus-filled blisters) on the palms of the hands and soles of the feet. This condition often leads to redness, scaling, and thickening of the skin in these areas. It can be painful and is commonly associated with other skin conditions, such as psoriasis.

The primary treatment options for palmoplantar pustulosis include topical treatments, systemic therapies, biologics, and phototherapy. Topical treatments aim to reduce inflammation, manage symptoms, and prevent flare-ups, and may involve corticosteroids, vitamin D analogs, calcineurin inhibitors, keratolytics, or coal tar. These treatments are used in various healthcare settings, such as hospitals, dermatology clinics, and home care environments, and are distributed through multiple channels, including online pharmacies, retail pharmacies, and hospitals.

The palmoplantar pustulosis market research report is one of a series of new reports from The Business Research Company that provides palmoplantar pustulosis market statistics, including the palmoplantar pustulosis industry global market size, regional shares, competitors with the palmoplantar pustulosis market share, detailed palmoplantar pustulosis market segments, market trends, and opportunities, and any further data you may need to thrive in the palmoplantar pustulosis industry. This palmoplantar pustulosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The palmoplantar pustulosis market size has grown strongly in recent years. It will grow from $1.93 billion in 2024 to $2.10 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth observed during the historical period can be attributed to factors such as the increasing prevalence of autoimmune disorders, greater awareness of rare skin diseases, higher healthcare spending, and the growing adoption of telemedicine in dermatology.

The palmoplantar pustulosis market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period is expected to be driven by the rising adoption of biologic therapies, increased investments in dermatology research, a growing pipeline of novel treatments, rising demand for personalized medicine, and the increasing prevalence of chronic skin conditions. Key trends for the forecast period include advancements in dermatology research, a shift toward biologics and immunomodulators, the integration of artificial intelligence in dermatological diagnosis, the development of advanced topical formulations, and the use of machine learning in dermatological research.

The rising prevalence of skin disorders is expected to drive the growth of the palmoplantar pustulosis market. Skin disorders are conditions that impact the skin's structure, function, or appearance, and their increasing incidence is attributed to environmental changes, lifestyle habits, and genetic factors. Environmental influences, such as air pollution, extreme weather conditions, and exposure to harmful chemicals, can irritate the skin and trigger conditions such as eczema or acne. Palmoplantar pustulosis is a chronic skin disorder that primarily affects the palms of the hands and soles of the feet, causing pustules, redness, and scaling. This condition can be managed with various treatments to improve skin health and reduce discomfort. For example, in 2022, the International Eczema Council reported that approximately 223 million people worldwide were affected by atopic dermatitis, with 43 million of them aged between 1 and 4 years old. As skin disorders become more prevalent, the growth of the palmoplantar pustulosis market is accelerating.

Companies in the palmoplantar pustulosis market are developing innovative treatments, such as monoclonal antibodies targeting inflammatory pathways, to improve patient outcomes. Monoclonal antibodies (mAbs) are identical antibodies produced by a single B cell clone and are designed to target specific antigens for therapeutic or diagnostic purposes. For example, in August 2023, Kyowa Kirin Co., Ltd., a Japan-based pharmaceutical company, received partial approval for LUMICEF for palmoplantar pustulosis treatment in Japan. LUMICEF is a targeted therapy that blocks IL-17, providing rapid and lasting relief for inflammatory conditions such as psoriasis and palmoplantar pustulosis. Its goal is to reduce inflammation and enhance the quality of life for patients with chronic skin diseases.

In October 2024, Organon & Co., a U.S.-based pharmaceutical company, acquired Dermavant Sciences Ltd. for an undisclosed sum. This acquisition allows Organon to strengthen its dermatology portfolio and improve women's health by offering innovative treatments for chronic skin conditions. Dermavant Sciences, based in the U.S., is focused on developing novel therapies for immuno-dermatological conditions, particularly targeting unmet needs in diseases such as plaque psoriasis and atopic dermatitis.

Major players in the palmoplantar pustulosis market are Pfizer Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis International AG, GlaxoSmithKline PLC (GSK), Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Bausch Health Companies Inc., Chugai Pharmaceutical Co. Ltd., Janssen Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Swedish Orphan Biovitrum AB (Sobi), Almirall S.A., MorphoSys AG, MoonLake Immunotherapeutics AG, Aristea Therapeutics Inc., AnaptysBio Inc., Taiho Pharmaceutical Co. Ltd., Kamari Pharma Ltd.

North America was the largest region in the palmoplantar pustulosis market in 2024. The regions covered in palmoplantar pustulosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the palmoplantar pustulosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The palmoplantar pustulosis market consists of revenues earned by entities by providing services such as personalized skincare and counseling, phototherapy services, pharmacological treatment services, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The palmoplantar pustulosis market also includes sales of phototherapy devices, oral systemic therapies, medicated skincare products, topical corticosteroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Palmoplantar Pustulosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on palmoplantar pustulosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for palmoplantar pustulosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The palmoplantar pustulosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Topical Treatments; Systemic Treatments; Biologics; Phototherapy
• 2) By Application: Hospitals; Dermatology Clinics; Homecare Settings
• 3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospitals
• Subsegments:
• 1) By Topical Treatments: Corticosteroids; Vitamin D Analogues; Calcineurin Inhibitors; Keratolytics
• 2) By Systemic Treatments: Retinoids; Immunosuppressants; Phosphodiesterase-4 (PDE4) Inhibitors; Corticosteroids
• 3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin-17 (IL-17) Inhibitors; Interleukin-23 (IL-23) Inhibitors; Interleukin-12/23 (IL-12/23) Inhibitors
• 4) By Phototherapy: Narrowband UVB Therapy (NB-UVB); Psoralen plus Ultraviolet A (PUVA) Therapy; Excimer Laser Therapy; Targeted Phototherapy
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Sanofi S.A.; Bristol-Myers Squibb Company; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Palmoplantar Pustulosis Market Characteristics

3. Palmoplantar Pustulosis Market Trends And Strategies

4. Palmoplantar Pustulosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Palmoplantar Pustulosis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Palmoplantar Pustulosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Palmoplantar Pustulosis Market Growth Rate Analysis
• 5.4. Global Palmoplantar Pustulosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Palmoplantar Pustulosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Palmoplantar Pustulosis Total Addressable Market (TAM)

6. Palmoplantar Pustulosis Market Segmentation

• 6.1. Global Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Treatments
• Systemic Treatments
• Biologics
• Phototherapy
• 6.2. Global Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Dermatology Clinics
• Homecare Settings
• 6.3. Global Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online Pharmacies
• Retail Pharmacies
• Hospitals
• 6.4. Global Palmoplantar Pustulosis Market, Sub-Segmentation Of Topical Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Vitamin D Analogues
• Calcineurin Inhibitors
• Keratolytics
• 6.5. Global Palmoplantar Pustulosis Market, Sub-Segmentation Of Systemic Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retinoids
• Immunosuppressants
• Phosphodiesterase-4 (PDE4) Inhibitors
• Corticosteroids
• 6.6. Global Palmoplantar Pustulosis Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tumor Necrosis Factor (TNF) Inhibitors
• Interleukin-17 (IL-17) Inhibitors
• Interleukin-23 (IL-23) Inhibitors
• Interleukin-12/23 (IL-12/23) Inhibitors
• 6.7. Global Palmoplantar Pustulosis Market, Sub-Segmentation Of Phototherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Narrowband UVB Therapy (NB-UVB)
• Psoralen plus Ultraviolet A (PUVA) Therapy
• Excimer Laser Therapy
• Targeted Phototherapy

7. Palmoplantar Pustulosis Market Regional And Country Analysis

• 7.1. Global Palmoplantar Pustulosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Palmoplantar Pustulosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Palmoplantar Pustulosis Market

• 8.1. Asia-Pacific Palmoplantar Pustulosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Palmoplantar Pustulosis Market

• 9.1. China Palmoplantar Pustulosis Market Overview
• 9.2. China Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Palmoplantar Pustulosis Market

• 10.1. India Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Palmoplantar Pustulosis Market

• 11.1. Japan Palmoplantar Pustulosis Market Overview
• 11.2. Japan Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Palmoplantar Pustulosis Market

• 12.1. Australia Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Palmoplantar Pustulosis Market

• 13.1. Indonesia Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Palmoplantar Pustulosis Market

• 14.1. South Korea Palmoplantar Pustulosis Market Overview
• 14.2. South Korea Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Palmoplantar Pustulosis Market

• 15.1. Western Europe Palmoplantar Pustulosis Market Overview
• 15.2. Western Europe Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Palmoplantar Pustulosis Market

• 16.1. UK Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Palmoplantar Pustulosis Market

• 17.1. Germany Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Palmoplantar Pustulosis Market

• 18.1. France Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Palmoplantar Pustulosis Market

• 19.1. Italy Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Palmoplantar Pustulosis Market

• 20.1. Spain Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Palmoplantar Pustulosis Market

• 21.1. Eastern Europe Palmoplantar Pustulosis Market Overview
• 21.2. Eastern Europe Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Palmoplantar Pustulosis Market

• 22.1. Russia Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Palmoplantar Pustulosis Market

• 23.1. North America Palmoplantar Pustulosis Market Overview
• 23.2. North America Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Palmoplantar Pustulosis Market

• 24.1. USA Palmoplantar Pustulosis Market Overview
• 24.2. USA Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Palmoplantar Pustulosis Market

• 25.1. Canada Palmoplantar Pustulosis Market Overview
• 25.2. Canada Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Palmoplantar Pustulosis Market

• 26.1. South America Palmoplantar Pustulosis Market Overview
• 26.2. South America Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Palmoplantar Pustulosis Market

• 27.1. Brazil Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Palmoplantar Pustulosis Market

• 28.1. Middle East Palmoplantar Pustulosis Market Overview
• 28.2. Middle East Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Palmoplantar Pustulosis Market

• 29.1. Africa Palmoplantar Pustulosis Market Overview
• 29.2. Africa Palmoplantar Pustulosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Palmoplantar Pustulosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Palmoplantar Pustulosis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Palmoplantar Pustulosis Market Competitive Landscape And Company Profiles

• 30.1. Palmoplantar Pustulosis Market Competitive Landscape
• 30.2. Palmoplantar Pustulosis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Palmoplantar Pustulosis Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline PLC (GSK)
• 31.2. Amgen Inc.
• 31.3. C.H. Boehringer Sohn AG & Co. KG
• 31.4. Bausch Health Companies Inc.
• 31.5. Chugai Pharmaceutical Co. Ltd.
• 31.6. Janssen Pharmaceuticals Inc.
• 31.7. Kyowa Kirin Co. Ltd.
• 31.8. Swedish Orphan Biovitrum AB (Sobi)
• 31.9. Almirall S.A.
• 31.10. MorphoSys AG
• 31.11. MoonLake Immunotherapeutics AG
• 31.12. Aristea Therapeutics Inc.
• 31.13. AnaptysBio Inc.
• 31.14. Taiho Pharmaceutical Co. Ltd.
• 31.15. Kamari Pharma Ltd.

32. Global Palmoplantar Pustulosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Palmoplantar Pustulosis Market

34. Recent Developments In The Palmoplantar Pustulosis Market

35. Palmoplantar Pustulosis Market High Potential Countries, Segments and Strategies

• 35.1 Palmoplantar Pustulosis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Palmoplantar Pustulosis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Palmoplantar Pustulosis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer